Edition:
United Kingdom

Penumbra Inc (PEN.N)

PEN.N on New York Stock Exchange

148.20USD
22 Jun 2018
Change (% chg)

$-2.60 (-1.72%)
Prev Close
$150.80
Open
$151.45
Day's High
$152.80
Day's Low
$147.25
Volume
1,632,340
Avg. Vol
82,804
52-wk High
$167.30
52-wk Low
$77.75

Chart for

About

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address... (more)

Overall

Beta: --
Market Cap(Mil.): $3,181.32
Shares Outstanding(Mil.): 33.77
Dividend: --
Yield (%): --

Financials

  PEN.N Industry Sector
P/E (TTM): 568.63 32.19 32.74
EPS (TTM): 0.17 -- --
ROI: 2.91 13.89 14.38
ROE: 2.96 16.72 16.08

BRIEF-Penumbra, Inc. Reports Qtrly Earnings Per Share $0.15

* PENUMBRA, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

08 May 2018

BRIEF-Penumbra Inc Sees FY 2018 Revenue $400 Mln To $405 Mln

* PENUMBRA, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Penumbra Announces Formation of Joint Venture, MVI Health

* PENUMBRA ANNOUNCES THE FORMATION OF JOINT VENTURE, MVI HEALTH

04 Jan 2018

Competitors

  Price Chg
Terumo Corp (4543.T) ¥6,680 -90.00
Johnson & Johnson (JNJ.N) $122.84 +1.39
Medtronic PLC (MDT.N) $86.81 +0.51
Stryker Corporation (SYK.N) $172.00 +2.19
Boston Scientific Corporation (BSX.N) $32.62 +0.47

Earnings vs. Estimates